Diversity in Clinical Trials
MHP and RPM to democratize access to trials and increase diversity access for clinical trials and care.
Moderator: Taren Grom
Tami Klerr, Executive VP and Chief Business Development & Marketing Officer, PRA Health Sciences, 2012 PharmaVOICE 100
Kent Thoelke, Executive Vice President and Chief Scientific Officer, PRA Health Sciences, 2013 PharmaVOICE 100
Elizabeth Garner, MD, Chief Medical Officer, ObsEva, 2019 PharmaVOICE 100
Jessica Scott, MD, JD, Head of R&D Patient Engagement Office, Takeda Pharmaceutical Company, 2020 PharmaVOICE 100